(Q38597238)

4 September 2017

title

The Latent Membrane Protein 1 (LMP1). (English)

1 reference

4 September 2017

1 reference

Arnd Kieser

1

1 reference

4 September 2017

Kai R Sterz

series ordinal

2

1 reference

4 September 2017

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

391

1 reference

4 September 2017

page(s)

119-149

1 reference

Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Expression of the vault RNA protects cells from undergoing apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Animal models of Epstein Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The LMP1 promoter can be transactivated directly by NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Genome-wide siRNA screen for mediators of NF-κB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

A role for protein kinase PKR in the mediation of Epstein-Barr virus latent membrane protein-1-induced IL-6 and IL-10 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

RECK is a target of Epstein–Barr virus latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

LMP1 strain variants: biological and molecular properties.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Unique signaling properties of CTAR1 in LMP1-mediated transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Human tumor virus utilizes exosomes for intercellular communication.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Sequence variation in the Epstein-Barr virus latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus: a group 1 carcinogen?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Expression of the Cytoplasmic Tail of LMP1 in Mice Induces Hyperactivation of B Lymphocytes and Disordered Lymphoid Architecture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The pathogenesis of Epstein-Barr virus persistent infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The significance of LMP1 expression in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Regulation and function of NF-kappaB transcription factors in the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interferon regulatory factor 7 is involved in the growth of Epstein-Barr virus-transformed human B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The structural basis for the recognition of diverse receptor sequences by TRAF2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus: 40 years on

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

The NF-κB genomic landscape in lymphoblastoid B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_4

10.1007/978-3-319-22834-1_4

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference